Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Extra-cerebellar motor symptoms in Angelman’s syndrome

Angelman’s syndrome (AS) is a severe neurological disorder that is characterized by a range of neurobehavioral deficits, including motor and balance impairments. Mutations that silence the maternally imprinted UBE3A gene underlie AS, although little is known regarding the neural circuit-level dysfunction that mediates AS symptoms. Ataxia and tremor are present in both AS and cerebellar disorders, supporting the hypothesis that AS motor impairments are cerebellar in origin. However, no direct testing of this hypothesis has previously been performed. Caroline Bruinsma and colleagues at the Erasmus University Medical Center measured cerebellum-dependent visual motor learning in a genetic mouse model of AS.  AS mice displayed locomotor impairments and mild deficits in cerebellum-dependent learning, as measured by the vestibular-ocular reflex phase-reversal test. Electrophysiological examinations of cerebellar circuitry in these mice revealed impaired tonic inhibition of granule cells, despite normal Purkinje cell physiology, thereby establishing a potential neurobiological correlate to the observed behavioral deficits. As it is unclear whether cerebellar learning deficits and locomotor impairments in AS mice both result from loss of cerebellar UBE3A expression, the authors developed an AS model in which UBE3A expression was partially restored in cerebellum but remained absent in the forebrain. These mice displayed normal cerebellar-dependent learning but impaired locomotion, suggesting that locomotor deficits in AS are likely mediated by UBE3A loss outside the cerebellum. The accompanying image shows UBE3A expression (brown) in the cerebellum of WT (left) mice and in animals with Purkinje cell-specific loss of UBE3A  (right). In WT animals, UBE3A expression (brown) is distinct within the Purkinje cell layer and completely absent in these cells of mutant mice. Lack of UBE3A in Purkinje cells does not affect cerebellar learning.  

Published October 20, 2015, by Daniel Albaugh

Scientific Show StopperNeuroscience

Related articles

Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model
Caroline F. Bruinsma, Martijn Schonewille, Zhenyu Gao, Eleonora M.A. Aronica, Matthew C. Judson, Benjamin D. Philpot, Freek E. Hoebeek, Geeske M. van Woerden, Chris I. De Zeeuw, Ype Elgersma
Caroline F. Bruinsma, Martijn Schonewille, Zhenyu Gao, Eleonora M.A. Aronica, Matthew C. Judson, Benjamin D. Philpot, Freek E. Hoebeek, Geeske M. van Woerden, Chris I. De Zeeuw, Ype Elgersma
View: Text | PDF
Research Article Neuroscience

Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model

  • Text
  • PDF
Abstract

Angelman syndrome (AS) is a severe neurological disorder that is associated with prominent movement and balance impairments that are widely considered to be due to defects of cerebellar origin. Here, using the cerebellar-specific vestibulo-ocular reflex (VOR) paradigm, we determined that cerebellar function is only mildly impaired in the Ube3am–/p+ mouse model of AS. VOR phase-reversal learning was singularly impaired in these animals and correlated with reduced tonic inhibition between Golgi cells and granule cells. Purkinje cell physiology, in contrast, was normal in AS mice as shown by synaptic plasticity and spontaneous firing properties that resembled those of controls. Accordingly, neither VOR phase-reversal learning nor locomotion was impaired following selective deletion of Ube3a in Purkinje cells. However, genetic normalization of αCaMKII inhibitory phosphorylation fully rescued locomotor deficits despite failing to improve cerebellar learning in AS mice, suggesting extracerebellar circuit involvement in locomotor learning. We confirmed this hypothesis through cerebellum-specific reinstatement of Ube3a, which ameliorated cerebellar learning deficits but did not rescue locomotor deficits. This double dissociation of locomotion and cerebellar phenotypes strongly suggests that the locomotor deficits of AS mice do not arise from impaired cerebellar cortex function. Our results provide important insights into the etiology of the motor deficits associated with AS.

Authors

Caroline F. Bruinsma, Martijn Schonewille, Zhenyu Gao, Eleonora M.A. Aronica, Matthew C. Judson, Benjamin D. Philpot, Freek E. Hoebeek, Geeske M. van Woerden, Chris I. De Zeeuw, Ype Elgersma

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts